CCL2 and ischemia: Our findings are consistent with evidence from various ischemia models, suggesting that elevated MCP-1 levels represent an immune response to ischemic injury and the coordinated recruitment of lymphocytes and monocytes to the site of damage shortly after the onset of ischemia [18].